Skip to main content

Lupin’s Safyral generic Tydemy gets FDA nod – Drug Store News

By December 18, 2017News
lupin-pharmaceuticals-logo

lupin-pharmaceuticals-logo

The Food and Drug Administration has approved Mumbai-based Lupin’s Tydemy. The product is a generic version of Bayer’s Safyral (drospirenone, ethinyl estradiol, and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg).

{iframe}http://www.drugstorenews.com/article/lupins-safyral-generic-tydemy-gets-fda-nod{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.